Results 301 to 310 of about 16,491,459 (401)

Sustainability in Analytical Chemistry Illustrated by Pharmaceutical Nitrosamine Testing

ELECTROPHORESIS, EarlyView.
ABSTRACT Following the valsartan scandal in 2018, the testing of drug substances and drug products for N‐nitrosamines has become a critical and mandatory quality control measure. The European Pharmacopoeia chapter 2.5.42 currently describes three analytical methods for this purpose: HPLC–MS/MS, GC–MS, and GC–MS/MS.
Felix Bredendiek, Sebastian Schmidtsdorff, Maria Kristina Parr   +2 more
wiley   +1 more source

Recommendations to advance equity in tobacco control. [PDF]

Tob Control
Mills SD, Rosario C, Yerger VB, Kalb MD, Ribisl KM.   +4 more
europepmc   +1 more source

Severity of effect considerations regarding the use of mutation as a toxicological endpoint for risk assessment: A report from the 8th International Workshop on Genotoxicity Testing (IWGT)

Environmental and Molecular Mutagenesis, EarlyView.
Abstract Exposure levels without appreciable human health risk may be determined by dividing a point of departure on a dose–response curve (e.g., benchmark dose) by a composite adjustment factor (AF). An “effect severity” AF (ESAF) is employed in some regulatory contexts.
Barbara L. Parsons, Marc A. Beal, Kerry L. Dearfield, George R. Douglas, Min Gi, B. Bhaskar Gollapudi, Robert H. Heflich, Katsuyoshi Horibata, Michelle Kenyon, Alexandra S. Long, David P. Lovell, Anthony M. Lynch, Meagan B. Myers, Stefan Pfuhler, Alisa Vespa, Andreas Zeller, George E. Johnson, Paul A. White   +17 more
wiley   +1 more source

Oral Tobacco and Nicotine Marketplace Trends Since the Tobacco Control Act.

JAMA Netw Open
Hrywna M, Wackowski OA, Robichaud MO, Talbot EM, Barnwell PV, Delnevo CD.   +5 more
europepmc   +1 more source

Tobacco Control and Smoking Cessation-Related Content in Oncology Meetings: A Systematic Scoping Review. [PDF]

JTO Clin Res Rep
Choi S, Chawla M, Catherwood P, Chen D, Huang RS, Boateng W, Do J, Khan M, Alghabban A, Quartey NK, Raman S, Giuliani ME, Evans WK, Eng L.   +13 more
europepmc   +1 more source

Late‐onset unexplained epilepsy as a risk factor for cognitive impairment and dementia: Protocol for a multi‐center prospective longitudinal observational study (ELUCID)

Epilepsia Open, EarlyView.
Abstract Objective Late‐onset unexplained epilepsy (LoUE), defined as epilepsy onset after age 55 without an obvious cause, is an important risk factor for dementia. Studies have shown that 10%–25% of individuals with LoUE develop dementia within 3–4 years following their first seizure.
Alice D. Lam, Emily L. Johnson, Rani A. Sarkis, Leah J. Blank, Tyler E. Gaston, Mouhsin M. Shafi, Rodrigo Zepeda, Kyle R. Pellerin, Nathalie Jette, Douglas N. Greve, Lori B. Chibnik, Rebecca E. Amariglio, Gad A. Marshall, M. Brandon Westover   +13 more
wiley   +1 more source

Tobacco control in complex emergencies: Policy case study of Ukraine. [PDF]

Tob Prev Cessat
Skipalskyi A, Habicht J, Ciobanu A, Tarasenko Y, Skapa T.   +4 more
europepmc   +1 more source

Addressing Heterogeneity in Binge Eating Disorder: A Cluster Analysis Approach Based on Age of Onset, Clinical and Psychopathological Features

European Eating Disorders Review, EarlyView.
ABSTRACT Objective This study investigates clinical heterogeneity in patients with binge eating disorder (BED) and its association with treatment outcomes. Methods A two‐step cluster analysis was conducted on a clinical sample of 196 BED patients, using an agglomerative hierarchical procedure based on both categorical and quantitative measures ...
Lucía Camacho‐Barcia, Lia T. Sánchez‐Salido, Jessica Jiménez del Toro, Roser Granero, Isabel Sánchez, Kim Supit, Nadia Micali, Katrin Elisabeth Giel, Susana Jiménez‐Murcia, Stephan Zipfel, Fernando Fernández‐Aranda   +10 more
wiley   +1 more source

The economic impact of smoke‐free policies on sales in restaurants and cafés in Victoria

Australian and New Zealand Journal of Public Health, 2003
Anita Lal, Mohammad Siahpush, Michelle Scollo   +2 more
doaj   +1 more source

Projecting the impact of strengthened tobacco control policy on disparities in US states with persistently high smoking rates. [PDF]

Tob Induc Dis
Donovan EM, Yoon SN, Hardy B, Kreslake J, Maciosek MV.   +4 more
europepmc   +1 more source